Isoxazole compound ML327 blocks MYC expression and tumor formation in neuroblastoma.
Rellinger EJ, Padmanabhan C, Qiao J, Craig BT, An H, Zhu J, Correa H, Waterson AG, Lindsley CW, Beauchamp RD, Chung DH.
Rellinger EJ, et al.
Oncotarget. 2017 Jul 20;8(53):91040-91051. doi: 10.18632/oncotarget.19406. eCollection 2017 Oct 31.
Oncotarget. 2017.
PMID: 29207623
Free PMC article.